High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience
β Scribed by Agarwal, R; Dvorak, C C; Stockerl-Goldstein, K E; Johnston, L; Srinivas, S
- Book ID
- 109840525
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 159 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C
## Background: Because outcome for metastatic rhabdomyosarcoma remains poor with standard therapy, and because some patients with extensive unresectable metastatic rhabdomyosarcoma are unable to tolerate standard therapy with the associated large radiation fields, peripheral blood stem cell rescue
## Abstract ## BACKGROUND. Highβdose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) has been reported to be effective in treating children with recurrent central nervous system (CNS) malignancies. ## METHODS. To evaluate the efficacy and toxicities of HDCT and ASCR, the medical reco